SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Apogee Therapeutics signed an Antibody Discovery Agreement with Paragon Therapeutics effective June 17, 2026, for discovery and development of monospecific antibody candidates. The…
CRH Americas and Neon Merger Sub have entered into an Agreement and Plan of Merger to acquire Arcosa Inc., effective June 21, 2026. The transaction combines two major players in th…
Ligand Pharmaceuticals entered into a fourth amendment to its credit agreement with Citibank as administrative agent, consenting to the issuance of up to $700 million in unsecured …
AbbVie announced a definitive agreement to acquire Apogee Therapeutics for $135.11 per share, totaling approximately $10.9 billion in equity value. The acquisition adds a clinical-…
TMCC's consolidated net income increased to $2.3 billion in fiscal 2026 from $1.7 billion in fiscal 2025, driven by lower interest expenses and higher financing revenues. The resul…
TScan Therapeutics announced positive initial data from Cohort C of the ALLOHA Phase 1 study, with 11 of 14 patients achieving complete donor chimerism within three weeks and 93% s…
MapLight Therapeutics announced topline data from its Phase 2 IRIS trial evaluating ML-004 for autism spectrum disorder treatment. The clinical trial results represent a key milest…
HawkEye 360 achieved record Q1 2026 revenue of $49.8 million with 116.5% year-over-year growth and a $285 million backlog, while completing an IPO that raised $435.9 million in net…
EyePoint's board approved Amendment No. 3 to its 2023 Long-Term Incentive Plan, increasing the maximum shares available for equity awards to 15.3 million, pending stockholder appro…
Fervo Energy completed a $2.2 billion IPO in May 2026 and reported a Q1 net loss of $31.8 million while advancing its Cape Station geothermal project toward Q4 2026 commercial oper…
CRH Americas, Inc. has entered into a definitive merger agreement to acquire Arcosa, Inc. through a merger with Neon Merger Sub, Inc. The transaction represents a significant conso…
MoonLake's sonelokimab achieved 67% HiSCR75 response rate and 26% inflammatory remission at Week 52 in hidradenitis suppurativa trials, with BLA submission expected September 2026.…
Traws Pharma announced it will resubmit an updated toxicology data package for tivoxavir marboxil to the UK's MHRA in Q3 2026 to advance a Phase 2a human influenza challenge study.…
Nextpower agreed to acquire Germany-based solar technology provider Zimmermann PV-Steel Group for approximately €330 million in cash and stock, expanding its product portfolio and …
uniQure announced preliminary six-month data from its Phase I/IIa trial of AMT-260 for refractory mesial temporal lobe epilepsy, with three of six patients achieving 79-100% seizur…
Nova Minerals successfully redomiciled to the United States with stock now trading on NYSE American, while commencing drilling at antimony and gold projects in Alaska. The company …
IQM Quantum Computers appointed Craig Ciesla, former VP of Engineering at 10x Genomics, as Chief Technology Officer, and promoted Inés de Vega to Chief Scientist. The moves strengt…
RTB Digital announced a real-time payment infrastructure enabling nearly 200 professional publishers to receive USDC instantly upon earning ad revenue, partnering with Coinbase. Th…
Ross Gerber Says SpaceX Could Build A 'Great AI Phone’ Through Starlink To Challenge Apple, Gets Told Google's Pixel Already Does What He Wants
Michael Burry Unlocks Research For Father's Day, Says AI Will Create Software Winners And Losers: Here Are The Stocks He Highlighted